Brief report: a double-blind study of naltrexone in infantile autism.
Leboyer
M
M
INSERM U 155--Unité de Recherche en Génétique Epidémologique, Paris.
Bouvard
M P
MP
Launay
J M
JM
Tabuteau
F
F
Waller
D
D
Dugas
M
M
Kerdelhue
B
B
Lensing
P
P
Panksepp
J
J
D000293:Adolescent; D001127:Arginine Vasopressin / Q000097:blood; D001321:Autistic Disorder / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D002675:Child, Preschool; D004298:Dopamine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004837:Epinephrine / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D009271:Naltrexone / Q000627:therapeutic use*; D009638:Norepinephrine / Q000097:blood; D001615:beta-Endorphin / Q000097:blood
D001127:Arginine Vasopressin; D009271:Naltrexone; D001615:beta-Endorphin; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine